Time
|
Assessment tool 1
|
Assessment tool 2
|
N
|
Kendall’s tau-b
|
---|
Baseline
|
PHQ-9
|
BDI-II
|
14081
|
0.6294
|
3 months
|
R-SMS-DS
|
PHQ-9 Total
|
2202
|
0.5704
|
|
R-SMS-DS
|
PHQ-9 item 1
|
2192
|
0.5279
|
|
R-SMS-DS
|
PHQ-9 item 2
|
2202
|
0.5316
|
|
R-SMS-DS
|
PHQ-9 item 3
|
2192
|
0.3967
|
|
R-SMS-DS
|
PHQ-9 item 4
|
2192
|
0.4206
|
|
R-SMS-DS
|
PHQ-9 item 5
|
2182
|
0.4319
|
|
R-SMS-DS
|
PHQ-9 item 6
|
2192
|
0.5673
|
|
R-SMS-DS
|
PHQ-9 item 7
|
2202
|
0.4213
|
|
R-SMS-DS
|
PHQ-9 item 8
|
2192
|
0.3786
|
|
R-SMS-DS
|
PHQ-9 item 9
|
2202
|
0.4166
|
12 months
|
PHQ-9
|
BDI-II
|
5483
|
0.6632
|
- 1All patients screened at baseline.
- 2Patients in the SMS sub-study with text replies received within +/− 6 days of date of PHQ-9 completion.
- 3All patients in the ACUDep trial with response data.